VCYT | Veracyte, Inc.

Index- P/E- EPS (ttm)-0.42 Insider Own0.70% Shs Outstand72.18M Perf Week-3.29%
Market Cap1.88B Forward P/E- EPS next Y-0.40 Insider Trans-28.47% Shs Float71.03M Perf Month9.26%
Income-30.20M PEG- EPS next Q-0.15 Inst Own105.46% Short Float / Ratio5.25% / 5.46 Perf Quarter22.52%
Sales311.20M P/S6.03 EPS this Y54.10% Inst Trans0.36% Short Interest3.73M Perf Half Y-3.73%
Book/sh14.98 P/B1.72 EPS next Y29.80% ROA-2.60% Target Price31.67 Perf Year38.92%
Cash/sh2.45 P/C10.54 EPS next 5Y- ROE-2.80% 52W Range14.92 - 32.40 Perf YTD8.89%
Dividend- P/FCF264.19 EPS past 5Y11.00% ROI-3.80% 52W High-20.25% Beta1.38
Dividend %- Quick Ratio4.30 Sales past 5Y32.70% Gross Margin66.50% 52W Low73.19% ATR1.18
Employees787 Current Ratio4.50 Sales Q/Q21.50% Oper. Margin-11.70% RSI (14)56.65 Volatility4.04% 4.76%
OptionableYes Debt/Eq0.00 EPS Q/Q44.80% Profit Margin-9.70% Rel Volume0.70 Prev Close25.90
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout- Avg Volume681.93K Price25.84
Recom2.10 SMA201.60% SMA509.82% SMA20012.11% Volume480,709 Change-0.23%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Downgrade Raymond James Outperform → Mkt Perform
Jan-05-23Initiated Scotiabank Sector Outperform $33
Jan-07-22Initiated Stephens Overweight $52
Nov-18-21Resumed Goldman Buy $60
Jun-15-21Initiated Raymond James Outperform $45
Feb-18-21Resumed Needham Buy $88
Jan-28-21Initiated Truist Buy $61
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $48
Sep-09-20Initiated Morgan Stanley Underweight $35
Jul-31-19Initiated Lake Street Buy $35
Nov-26-13Initiated William Blair Outperform
May-30-23 06:56AM
May-25-23 05:13PM
May-24-23 09:00AM
May-23-23 05:00PM
May-22-23 07:30AM
06:15AM Loading…
May-12-23 06:15AM
May-05-23 01:59PM
May-04-23 06:25PM
04:05PM
09:45AM
May-03-23 05:44PM
08:30AM
May-02-23 04:05PM
May-01-23 05:35PM
Apr-29-23 04:31PM
04:05PM Loading…
Apr-27-23 04:05PM
10:02AM
09:55AM
Apr-18-23 09:48AM
Apr-17-23 08:30AM
Apr-13-23 05:00PM
Apr-12-23 08:30AM
Mar-23-23 06:54AM
Mar-15-23 04:15PM
11:44AM
Mar-11-23 12:11PM
Mar-10-23 09:30AM
Feb-27-23 05:00PM
Feb-24-23 05:42AM
Feb-22-23 06:15PM
04:05PM Loading…
04:05PM
Feb-15-23 08:36AM
Feb-13-23 05:23PM
10:14AM
Feb-06-23 05:00PM
Feb-01-23 04:05PM
08:32AM
Jan-24-23 10:23AM
Jan-23-23 09:00AM
Jan-18-23 06:10AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Dec-15-22 04:05PM
Dec-12-22 12:00PM
Dec-01-22 02:46PM
Nov-09-22 06:15AM
Nov-02-22 06:55PM
04:05PM
Nov-01-22 05:11PM
Oct-27-22 05:00PM
Oct-25-22 08:30AM
Oct-24-22 08:30AM
Oct-18-22 04:05PM
Oct-17-22 01:58PM
Oct-13-22 05:00PM
Sep-24-22 06:30AM
Sep-22-22 08:55AM
Sep-13-22 08:30AM
Sep-11-22 02:30AM
Sep-07-22 04:54PM
Sep-01-22 05:00PM
Aug-31-22 07:00AM
Aug-29-22 11:19AM
Aug-14-22 11:13AM
Aug-11-22 04:05PM
Aug-02-22 05:55PM
04:05PM
Jul-28-22 09:48AM
Jul-22-22 11:23AM
Jul-20-22 04:15PM
Jul-14-22 04:30PM
Jul-13-22 04:15PM
Jul-05-22 09:55AM
Jun-30-22 10:50AM
Jun-27-22 08:15AM
Jun-20-22 08:15AM
Jun-15-22 06:15AM
Jun-03-22 08:30AM
May-31-22 04:20PM
May-26-22 05:10PM
05:05PM
08:15AM
May-16-22 04:17PM
May-12-22 04:36PM
08:30AM
May-09-22 02:55PM
May-04-22 08:30AM
May-03-22 06:15PM
04:05PM
May-02-22 04:18PM
04:01PM
Apr-28-22 04:15PM
Apr-26-22 04:05PM
Apr-19-22 08:15AM
Apr-08-22 06:50AM
Mar-01-22 04:05PM
Feb-28-22 06:25PM
04:05PM
08:30AM
Feb-24-22 07:40PM
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhanji MunaDirectorMay 30Sale25.911,53939,87524,733Jun 01 05:06 PM
Anderson Bonnie HDirectorApr 14Option Exercise5.6134,000190,74076,681Apr 18 04:44 PM
Anderson Bonnie HDirectorApr 14Sale22.0434,000749,35742,681Apr 18 04:44 PM
EASTHAM KARINDirectorMar 16Option Exercise12.1218,750227,25042,201Mar 17 04:38 PM
EASTHAM KARINDirectorMar 16Sale22.7818,750427,04423,451Mar 17 04:38 PM
Anderson Bonnie HDirectorMar 15Option Exercise5.6134,000190,74087,967Mar 16 04:54 PM
Anderson Bonnie HDirectorMar 15Sale22.7634,000773,88853,967Mar 16 04:54 PM
EASTHAM KARINDirectorFeb 28Option Exercise12.1210,000121,20033,451Mar 02 04:16 PM
EASTHAM KARINDirectorFeb 28Sale25.0010,000250,00123,451Mar 02 04:16 PM
Anderson Bonnie HDirectorJan 17Option Exercise5.6134,000190,74096,961Jan 18 05:08 PM
Anderson Bonnie HDirectorJan 17Sale26.3534,000895,83862,961Jan 18 05:08 PM
Anderson Bonnie HDirectorJan 11Option Exercise14.3463,247906,962126,208Jan 12 05:27 PM
Anderson Bonnie HDirectorJan 11Sale25.1363,2471,589,19562,961Jan 12 05:27 PM
JONES EVAN/ FADirectorDec 14Sale30.1360018,08050,184Dec 16 05:04 PM
JONES EVAN/ FADirectorDec 13Sale30.711,66751,19750,784Dec 15 05:00 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 06Sale27.031,02327,65265,970Dec 08 05:18 PM
Anderson Bonnie HExecutive ChairwomanDec 01Option Exercise11.0780,000885,300145,003Dec 05 04:56 PM
Anderson Bonnie HExecutive ChairwomanDec 01Sale28.2680,0002,260,74865,003Dec 05 04:56 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 11Option Exercise14.3422968,003Nov 15 05:02 PM
JONES EVAN/ FADirectorNov 11Sale30.236,000181,35752,451Nov 15 04:54 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 11Sale29.3425968,001Nov 15 05:02 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 04Sale25.001,02325,57568,001Nov 08 05:44 PM
Anderson Bonnie HExecutive ChairwomanOct 13Option Exercise9.0211,08899,99676,091Oct 17 05:05 PM
Holstein JensDirectorJun 14Sale16.278,720141,8462,000Jun 16 08:04 PM